Introduction: From Funding Frenzy to Selective Capital Just a few years ago, biotech funding felt unstoppable. Mega rounds Rapid IPOs Sky-high valuations But in 2026, the landscape has changed. Capital

Introduction: Regulation as a Strategic Milestone in Biotech For biotechnology startups, scientific breakthroughs are only one part of the journey to market success. Navigating regulatory pathways is equally critical. From

Introduction: From Concept to Clinical Standard Precision medicine is no longer a futuristic promise, it’s rapidly becoming the clinical default. In 2026, breakthroughs in genomics, AI-powered diagnostics, gene editing, and

It’s just past sunrise when the lights flicker on inside the lab. Pipettes are lined up, data dashboards glow softly, and a small team of researchers gathers around a whiteboard

When 28-year-old Meera Rao,  an Indian biotech founder,  posted on LinkedIn,  “We thought the check had dried up. Then, late-Sept,  a lead investor called, ” it caught attention. Her startup, 

After years of quiet, biotech is roaring back,  and 2025 may well be its breakout act. Introduction In the hush of the pandemic era and the retrenchment of risk capital,

Bitcoin (BTC) is a crypto in the CRYPTO market. The price is 111,765.0 USD currently with a change of +2,348.00 (0.02146%) from the previous close. The intraday high is 112,340.0